Fabrice Morlet

Chief AI & Data Officer at Ramsay Santé

Fabrice Morlet currently serves as the Chief AI & Data Officer at Ramsay Santé since May 2022. Previously, Fabrice was the CEO and founder of audéOrg consulting from September 2014 to May 2022. Experienced in IT and data strategy, Fabrice held roles such as overseeing IT audits and strategy at Robertet Group, managing cloud transition programs at Imerys, and designing digital roadmaps for Total Energies with Kearney. Additional experience includes leadership in data transformation programs for companies like Arkema and Yves Rocher, as well as implementing digital initiatives for Moët Hennessy Diageo France and developing digital solutions for LVMH Perfumes & Cosmetics. Fabrice holds an Ingenior degree in Systems Information from Icam - Institut Catholique d'Arts et Métiers, earned between 1994 and 1997.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Ramsay Santé

1 followers

After the acquisition of the Capio Group in 2018, Ramsay Santé has become Europe's leading private hospital and primary care companies. The group now has 36,000 employees and works with nearly 8,600 private practitioners. Present in 5 countries, France, Sweden, Norway, Denmark and Italy, the group treats more than 7 million patients per year in its 350 establishments. In hospitalization, Ramsay Santé offers almost all medical and surgical treatments in three business lines: Medicine-Surgery-Obstetrics (MCO), Follow-up and Rehabilitation Care (SSR) and Mental Health. Wherever it is present, the group participates in public health service missions and in the health network of the country, as in Sweden where the group has more than a hundred local health centres. The quality and safety of care is the group's priority in all the countries where it operates. This is why the group is today one of the references in modern medicine, especially in ambulatory surgery and enhanced recovery after surgery (ARS). The group also invests more than €200 million every year in its establishments, whether in new surgical and imaging technologies, or in the construction and modernisation of establishments. It also innovates at the service of patients with new digital tools and by developing its organisations to improve the efficiency of care.


Employees

10,000+

Links